Celldex to Report Second Quarter 2009 Financial Results on August 5, 2009

- Conference Call to Follow -
NEEDHAM, Mass.--(Business Wire)--
Celldex Therapeutics, Inc. (NASDAQ: CLDX) will release its second quarter 2009
financial results before U.S. financial markets open on Wednesday, August 5,
2009.

Celldex executives will host a conference call at 9:00 am ET that same day. The
conference call will be webcast live over the Internet and can be accessed by
logging on to the "News & Events" section of the Celldex Therapeutics website at
www.celldextherapeutics.com. The call can also be accessed by dialing
888-713-4216 (within the United States) or 617-213-4868 (outside the United
States). The passcode for participants is 31965468.

A replay of the call will be available approximately two hours after the live
call concludes through August 12, 2009. To access the replay, dial 888-286-8010
(within the United States) or 617-801-6888 (outside the United States). The
passcode is 59806260. The webcast will also be archived on the Company`s
website.

About Celldex Therapeutics, Inc.

Celldex Therapeutics is an integrated biopharmaceutical company that applies its
comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline
of candidates to treat cancer and other difficult-to-treat diseases. Celldex`s
immunotherapy platform includes a complementary portfolio of monoclonal
antibodies, antibody-targeted vaccines and immunomodulators to create novel
disease-specific drug candidates. For more information, please visit
http://www.celldextherapeutics.com.

Celldex Therapeutics, Inc.
Anthony S. Marucci, 781-433-0771
President and CEO
or
Celldex Therapeutics, Inc.
Avery W. Catlin, 781-433-0771
Chief Financial Officer
IR@celldextherapeutics.com
or
For Media:
BMC Communications Group
Daniel Budwick, 973-271-6085
dbudwick@bmccommunications.com

Copyright Business Wire 2009